The effectiveness and value of lecanemab for early Alzheimer disease: A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum.

Authors :: Wright AC
Lin GA
Whittington MD
Agboola F
Herron-Smith S
Rind D
Pearson SD
Source :: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2023 Sep; Vol. 29 (9), pp. 1078-1083.
Publication Year :: 2023

Subjects :: Humans
Technology Assessment, Biomedical
Cost-Benefit Analysis
Academies and Institutes
Alzheimer Disease drug therapy

Full Text Access

Tools